Evidence map›Paper›PMID 32993102›Full record

ArticleBiomolecules2020

Sphaerostilbellins, New Antimicrobial Aminolipopeptide Peptaibiotics from

Bruno Perlatti, Connie B Nichols, J Andrew Alspaugh, James B Gloer, Gerald F Bills

Abstract read
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bruno PerlattiTexas Therapeutic Institute, The Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77054, USA.ORCID 0000-0002-4403-3387
Connie B NicholsDepartments of Medicine and Molecular Genetics & Microbiology, Duke University Medical Center, Durham, NC 27710, USA.
J Andrew AlspaughDepartments of Medicine and Molecular Genetics & Microbiology, Duke University Medical Center, Durham, NC 27710, USA.ORCID 0000-0003-3009-627X
James B GloerDepartment of Chemistry, University of Iowa, Iowa City, IA 52242, USA.
Gerald F BillsTexas Therapeutic Institute, The Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77054, USA.ORCID 0000-0003-2352-8417

Funding

Coordinated Regulation of Virulence Genes in C. neoformansR01AI074677 · NIAID · DUKE UNIVERSITY · PI ALSPAUGH, ANDREW, WORMLEY, FLOYD L. · 2011 to 2020
$4.0M
Mining the Coprophilous Mycobiome for New Cryptococcus Antiinfectives and Antifungal SynergistsR01GM121458 · NIGMS · UNIVERSITY OF IOWA · PI ALSPAUGH, ANDREW, AN, ZHIQIANG · 2017 to 2020
$2.1M
NIGMS NIH HHS R01 GM121458NIH HHS R01 AI074677NIH HHS R01 GM121458
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAnti-Bacterial AgentsAntifungal AgentsAnti-Infective AgentsAspergillus fumigatusBasidiomycotaCandida albicansCryptococcus neoformansHumansMacrophagesMiceMicrobial Sensitivity TestsStaphylococcus aureusAnti-Bacterial AgentsAntifungal AgentsAnti-Infective AgentsantifungalsHypocreaceaemycoparasitenonribosomal peptideputrescinesecondary metabolite

Identifiers

PMID32993102
PMCPMC7600149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.